Olema Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−12.65%
vs ±30.4% implied · ×0.42
shaded = implied · ▲▼ = realized
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $151.9M | 11.81% | +16.91% | |
| 2 | Paradigm Biocapital AdvisorsParadigm Biocapital | $108.5M | 8.43% | +8.10% | |
| 3 | Jupiter TopcoJupiter Topco | $88.8M | 6.90% | — | |
| 4 | Bain Capital Life Sciences InvestorsBain Capital Life Sciences Investors | $88.6M | 6.89% | −5.19% | |
| 5 | BlackRockBlackRockindex-like | $84.0M | 6.53% | +18.80% | |
| 6 | BVFBVF | $66.3M | 5.15% | 0.00% | |
| 7 | SirenSiren | $60.8M | 4.72% | +2.10% | |
| 8 | State StreetState Streetindex-like | $54.0M | 4.20% | +9.60% | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $41.8M | 3.25% | +8.36% | |
| 10 | Logos Global ManagementLogos Global | $40.1M | 3.12% | 0.00% | |
| 11 | Franklin ResourcesFranklin Resources | $29.4M | 2.29% | +92.75% | |
| 12 | Cormorant Asset ManagementCormorant | $26.9M | 2.09% | −51.14% | |
| 13 | Morgan StanleyMorgan Stanley | $22.9M | 1.78% | +50.72% | |
| 14 | Geode Capital ManagementGeodeindex-like | $22.8M | 1.77% | +17.78% | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $20.8M | 1.62% | +180.46% | |
| 16 | Goldman Sachs GroupGoldman Sachs | $19.6M | 1.53% | +25.17% | |
| 17 | Deep Track CapitalDeep Track Capital | $18.8M | 1.46% | new | |
| 18 | Dimensional Fund AdvisorsDimensional | $17.7M | 1.38% | +30.87% | |
| 19 | Lightspeed ManagementLightspeed | $17.0M | 1.32% | 0.00% | |
| 20 | Kingdon Capital ManagementKingdon | $15.0M | 1.17% | +40.35% | |
| 21 | Two Sigma InvestmentsTwo Sigma | $14.2M | 1.10% | −3.25% | |
| 22 | Point72 Asset ManagementPoint72 | $13.7M | 1.06% | +896.61% | |
| 23 | Duquesne Family OfficeDuquesne Family Office | $12.3M | 0.96% | 0.00% | |
| 24 | Defilade Capital ManagementDefilade | $11.6M | 0.90% | −38.54% | |
| 25 | Ameriprise FinancialAmeriprise Financial | $10.5M | 0.82% | +1365.51% |
184 managers report $1.3B of Olema Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 23 of them hold 80% of it; FMR is largest at 11.81%.
Linked news
Olema Pharmaceuticals, Inc.
7.01
Expected move
No implied move.
No implied move.
No implied move.